On 21 April 2026 UAB “Atsinaujinančios energetikos investicijos” (hereinafter, the “Company”) has finished MEUR 2,029,000 series 1, tranche 3 bond issue at 8.50% yield, under its EUR 50 million ...

Frédéric Dupont-Aldiolan Named Chief Human Resources Officer, Architecting a Workforce Augmented by AI Sidetrade (Euronext Growth: ALBFR.PA), the AI-native Order-to-Cash company, today announces two ...

Results from Part 1 of the Phase 1b MUIR trial to be presented at annual meeting in June SAN DIEGO, April 21, 2026 (GLOBE NEWSWIRE)-- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical ...

Kitron has secured an order valued at approximately EUR 37 million for the production and supply of advanced radio systems used in tactical mobile platforms. Delivery of the order is scheduled to ...

Skyworks Solutions, Inc. (Nasdaq: SWKS), an innovator of high-performance analog and mixed-signal semiconductors connecting people, places and things, will host a conference call with analysts to ...

香港和寧波2026年4月21日 /美通社/ -- 均勝電子（699）首次同步發佈《2025年度可持續發展報告》和《2025年度自然相關資訊披露報告》。公司將可持續發展理念融入戰略與長遠發展，舊年在技術創新、綠色製造、社會責任踐行等方面成效顯著。公司亦已加入聯合國全球契約組織及責任商業聯盟，持續引領行業邁向更加綠色、繁榮的未來。 順應汽車智能、電動趨勢，均勝電子2025年投入約44.2億元加碼前瞻技 ...

SEOUL, South Korea, SHANGHAI and NEW YORK, April 21, 2026 /PRNewswire/ -- MemeMax, a perpetual decentralized exchange (Perp DEX), has officially launched, positioning itself as a trading ...

To Highlight Efficacy Results from Relapsed or Refractory Waldenström Macroglobulinemia Patients Treated with Iopofosine I 131 Immediately Following BTK Inhibitor Therapy FLORHAM PARK, N.J., April 21, ...

Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious ...

Standard Premium Finance Holdings, Inc. (OTCQX: SPFX) (“Standard Premium”), a leading specialty finance company, today announces its Annual Shareholders Meeting on June 12, 2026 in Miami, FL. The ...

Considering that during the shares buy-back process of INVL Technology (hereinafter – “the Company”), the Company acquired 8,525 shares for EUR 38,192 from the Company's shareholders for which they ...

Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the strategic formation of the industry's first ...